Fresh Hand Foaming Hand Sanitizer Non-alcohol Foam

Benzalkonium Chloride


Cwgc La Inc.
Human Otc Drug
NDC 70415-204
Fresh Hand Foaming Hand Sanitizer Non-alcohol Foam also known as Benzalkonium Chloride is a human otc drug labeled by 'Cwgc La Inc.'. National Drug Code (NDC) number for Fresh Hand Foaming Hand Sanitizer Non-alcohol Foam is 70415-204. This drug is available in dosage form of Solution. The names of the active, medicinal ingredients in Fresh Hand Foaming Hand Sanitizer Non-alcohol Foam drug includes Benzalkonium Chloride - .13 g/100mL . The currest status of Fresh Hand Foaming Hand Sanitizer Non-alcohol Foam drug is Active.

Drug Information:

Drug NDC: 70415-204
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Fresh Hand Foaming Hand Sanitizer Non-alcohol Foam
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Benzalkonium Chloride
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Cwgc La Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Solution
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:BENZALKONIUM CHLORIDE - .13 g/100mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH NOT FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 05 Aug, 2020
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 10 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part333A
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:CWGC LA Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:1020365
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:F5UM2KM3W7
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
70415-204-111000 mL in 1 BOTTLE (70415-204-11)05 Aug, 2020N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose antibacterial

Purpose antimicrobial

Product Elements:

Fresh hand foaming hand sanitizer non-alcohol foam benzalkonium chloride water coco glucoside laurtrimonium chloride cocamidopropylamine oxide anhydrous citric acid benzalkonium chloride benzalkonium

Indications and Usage:

Use for handwashing to decrease bacteria on the skin. recommended for repeated use.

Warnings:

Warnings for external use only. warning: harmful if swallowed. caution: keep out of eyes. in case of accidental eye contact, flush eyes thoroughly with water. if condition worsens or persists, contact a physician. if swallowed, contact a physician or poison control center immediately. when using this product avoid contact with eyes. in case of eye contact, flush with water keep out of reach of children. if swallowed, get medical help or contact a poison control center right away.

When Using:

When using this product avoid contact with eyes. in case of eye contact, flush with water

Dosage and Administration:

Directions apply foam sanitizer to hands and rub over surfaces of both hands for 15 seconds. no rinsing required.

Package Label Principal Display Panel:

01b lbl_non-alcohol foam_hand sanitizer


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.